Your browser doesn't support javascript.
loading
REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients.
Shitara, K; Yamanaka, T; Denda, T; Tsuji, Y; Shinozaki, K; Komatsu, Y; Kobayashi, Y; Furuse, J; Okuda, H; Asayama, M; Akiyoshi, K; Kagawa, Y; Kato, T; Oki, E; Ando, T; Hagiwara, Y; Ohashi, Y; Yoshino, T.
Affiliation
  • Shitara K; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Yamanaka T; Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan.
  • Denda T; Division of Gastroenterology, Chiba Cancer Center, Chiba, Japan.
  • Tsuji Y; Department of Medical Oncology, Tonan Hospital, Sapporo, Japan.
  • Shinozaki K; Division of Clinical Oncology, Hiroshima Prefectural Hospital, Hiroshima, Japan.
  • Komatsu Y; Division of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Japan.
  • Kobayashi Y; Department of Medical Oncology, Kushiro Rosai Hospital, Kushiro, Japan.
  • Furuse J; Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan.
  • Okuda H; Department of Medical Oncology, Keiyukai Sapporo Hospital, Sapporo, Japan.
  • Asayama M; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
  • Akiyoshi K; Department of Clinical Oncology, Osaka City General Hospital, Osaka, Japan.
  • Kagawa Y; Department of Surgery, Kansai Rosa Hospital, Amagasaki, Japan.
  • Kato T; Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Oki E; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Ando T; School of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Hagiwara Y; Department of Biostatistics, School of Public Health, The University of Tokyo, Tokyo, Japan.
  • Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Faculty of Science and Engineering, Chuo University, Tokyo, Japan.
  • Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan. Electronic address: tyoshino@east.ncc.go.jp.
Ann Oncol ; 30(2): 259-265, 2019 02 01.
Article in En | MEDLINE | ID: mdl-30508156
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Neoplasm Recurrence, Local Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Neoplasm Recurrence, Local Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: Japan